Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 1288-1291, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waits, R. P.
Right arrow Articles by Benson, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waits, R. P.
Right arrow Articles by Benson, M. D.

Clinical Chemistry, Vol 41, 1288-1291, Copyright © 1995 by American Association for Clinical Chemistry

Low plasma concentrations of retinol-binding protein in individuals with mutations affecting position 84 of the transthyretin molecule

RP Waits, T Yamada, T Uemichi and MD Benson
Program in Medical Neurobiology, Indiana University School of Medicine, Indianapolis, USA.

Retinol-binding protein (RBP), the principal carrier for vitamin A, is known to form a complex with transthyretin (TTR) for transport in plasma. Individuals from a kindred with the amino acid substitution of serine for isoleucine at position 84 (Ser84) of the TTR molecule show substantial reduction in plasma concentrations of RBP. In the present study, we measured plasma RBP in individuals from several kindreds, demonstrating 17 different point mutations within the TTR gene. In each case, these mutations caused single amino acid substitutions at various positions throughout the TTR molecule. Of all the individuals examined, only those with mutations causing amino acid substitutions at position 84 of the TTR molecule (Ser84 and Asn84) demonstrated substantial decreases in plasma concentrations of RBP. These results suggest that the isoleucine at position 84 on the TTR molecule may be critically involved in mediating RBP binding. Further, these findings demonstrate the importance of considering TTR gene mutations when clinically evaluating patients with low RBP.


The following articles in journals at HighWire Press have cited this article:


Home page
 Am J Trop Med HygHome page
B. L. L. Maciel, H. G. Lacerda, J. W. Queiroz, J. Galvao, N. N. Pontes, R. Dimenstein, S. E. McGowan, L. F. C. Pedrosa, and S. M. B. Jeronimo
Association of Nutritional Status with the Response to Infection with Leishmania chagasi
Am J Trop Med Hyg, October 1, 2008; 79(4): 591 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. Gueguen, P. Leroy, R. Gueguen, G. Siest, S. Visvikis, and B. Herbeth
Genetic and environmental contributions to serum retinol and {alpha}-tocopherol concentrations: the Stanislas Family Study
Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1034 - 1044.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
H. K Biesalski, J. Frank, S. C Beck, F. Heinrich, B. Illek, R. Reifen, H. Gollnick, M. W Seeliger, B. Wissinger, and E. Zrenner
Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol binding protein
Am. J. Clinical Nutrition, May 1, 1999; 69(5): 931 - 936.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.